Artemisinin treats SNU-C2A cell line for colorectal cancer by inhibiting cell growth through undergoing ferroptosis.
DOI:
https://doi.org/10.61173/9nykn277Keywords:
- Artemisinin, Colorectal Cancer, Ferropto-sis, SNU-C2A Cell LineAbstract
Colorectal cancer is one of the major types of cancer that humans are suffering from; however, drugs that can be used for treatment with no side effects have still not been discovered. By research, Chinese traditional medicine called artemisinin (ART) was known for undergoing ferroptosis in cells. Therefore, some experimental tests need to verify the effect of whether artemisinin allows ferroptosis to apply to colorectal cancer cells. The result of this experiment can allow a better understanding of the direction of colorectal cancer treatment and how Chinese traditional medicine can perform as treatments for CRC. Therefore, during this experiment, ART was used to test ferroptosis in the SNU-C2A colorectal cell line to see whether it’s a suitable drug to use for CRC patients.
References
[1] R. L. Siegel et al., “Colorectal cancer statistics, 2020,” CA. Cancer J. Clin., vol. 70, no. 3, pp. 145–164, 2020, doi: 10.3322/ caac.21601.
[2] P. Vega, F. Valentín, and J. Cubiella, “Colorectal cancer diagnosis: Pitfalls and opportunities,” World J. Gastrointest. Oncol., vol. 7, no. 12, pp. 422–433, Dec. 2015, doi: 10.4251/ wjgo.v7.i12.422.
[3] D. A. Joseph, J. B. King, N. F. Dowling, C. C. Thomas, and L. C. Richardson, “Vital Signs : Colorectal Cancer Screening Test Use — United States, 2018,” MMWR Morb. Mortal. Wkly. Rep., vol. 69, no. 10, pp. 253–259, Mar. 2020, doi: 10.15585/mmwr. mm6910a1.
[4] “Colorectal Cancer: Ablation and Embolization | Saint Luke’s Health System.” Accessed: Aug. 14, 2024. [Online]. Available: https://www.saintlukeskc.org/health-library/colorectal-cancer- Dean&Francis Yueh-Shan Chi ablation-and-embolization
[5] “SNU-C2A - CCL-250.1 | ATCC.” Accessed: Aug. 14, 2024. [Online]. Available: https://www.atcc.org/products/ccl-250.1
[6] J.-K. Chung et al., “@ Mechani sms Related to [ 8F] Fluorodeoxygluco se Uptake of Human Colon Cancers Transplanted in Nude Mice”.
[7] “Artemisinin: From Chinese Herbal Medicine to Modern Chemotherapy | HIMALAYA - The Journal of the Association for Nepal and Himalayan Studies.” Accessed: Aug. 14, 2024. [Online]. Available: https://journals.ed.ac.uk/himalaya/article/ view/7886
[8] “Malaria: Artemisinin partial resistance.” Accessed: Aug. 14, 2024. [Online]. Available: https://www.who.int/news-room/ questions-and-answers/item/artemisinin-resistance
[9] F. Gao, Z. Sun, F. Kong, and J. Xiao, “Artemisinin-derived hybrids and their anticancer activity,” Eur. J. Med. Chem., vol. 188, p. 112044, Feb. 2020, doi: 10.1016/j.ejmech.2020.112044.
[10] J. Li et al., “Ferroptosis: past, present and future,” Cell Death Dis., vol. 11, no. 2, pp. 1–13, Feb. 2020, doi: 10.1038/ s41419-020-2298-2.
[11] C. L. Ye et al., “STEAP3 Affects Ferroptosis and Progression of Renal Cell Carcinoma Through the p53/xCT Pathway,” Technol. Cancer Res. Treat., vol. 21, p. 15330338221078728, Jan. 2022, doi: 10.1177/15330338221078728.
[12] G. O. Latunde-Dada, “Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy,” Biochim. Biophys. Acta BBA - Gen. Subj., vol. 1861, no. 8, pp. 1893–1900, Aug. 2017, doi: 10.1016/j.bbagen.2017.05.019.
[13] T. M. Seibt, B. Proneth, and M. Conrad, “Role of GPX4 in ferroptosis and its pharmacological implication,” Free Radic. Biol. Med., vol. 133, pp. 144–152, Mar. 2019, doi: 10.1016/ j.freeradbiomed.2018.09.014.
[14] “The Potential Mechanisms by which Artemisinin and Its Derivatives Induce Ferroptosis in the Treatment of Cancer - Hu - 2022 - Oxidative Medicine and Cellular Longevity - Wiley Online Library.” Accessed: Aug. 26, 2024. [Online]. Available: https://onlinelibrary.wiley.com/doi/10.1155/2022/1458143
[15] “Current methodology of MTT assay in bacteria – A review - ScienceDirect.” Accessed: Aug. 26, 2024. [Online]. Available: https://www.sciencedirect.com/science/article/abs/pii/ S0065128118300278
[16] “Mechanochemistry as a Sustainable Method for the Preparation of Fluorescent Ugi BODIPY Adducts - Pérez‐ Venegas - 2021 - European Journal of Organic Chemistry - Wiley Online Library.” Accessed: Aug. 26, 2024. [Online]. Available: https://chemistry-europe.onlinelibrary.wiley.com/doi/ abs/10.1002/ejoc.202001267
[17] “Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research | Cancer Discovery | American Association for Cancer Research.” Accessed: Aug. 26, 2024. [Online]. Available: https://aacrjournals.org/cancerdiscovery/ article/4/9/998/6397/Patient-Derived-Xenograft-Models-An- Emerging
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
